NCT02061631 - Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

October 31, 2015

Conditions

Squamous Cell Carcinoma of Head and Neck

Interventions

DRUG

Cisplatin

Pharmaceutical form:solution Route of administration: intravenous

DRUG

DOCETAXEL XRP6976

Pharmaceutical form:solution Route of administration: intravenous

DRUG

Dexamethasone

Pharmaceutical form:tablet Route of administration: oral

DRUG

Dexamethasone

Pharmaceutical form:solution Route of administration: intravenous

Trial Locations (1)

Pakistan